APA (7th ed.) Citation

K, E., Z, V., R, O., J, J., M, L., A, H., . . . M, Y. (2022). Pediatric glioblastoma cells are sensitive to drugs that inhibit eIF2α dephosphorylation and its phosphomimetic S51D variant. Frontiers in oncology, 12, 959133. https://doi.org/10.3389/fonc.2022.959133

Chicago Style (17th ed.) Citation

K, Eytan, et al. "Pediatric Glioblastoma Cells Are Sensitive to Drugs That Inhibit EIF2α Dephosphorylation and Its Phosphomimetic S51D Variant." Frontiers in Oncology 12 (2022): 959133. https://doi.org/10.3389/fonc.2022.959133.

MLA (9th ed.) Citation

K, Eytan, et al. "Pediatric Glioblastoma Cells Are Sensitive to Drugs That Inhibit EIF2α Dephosphorylation and Its Phosphomimetic S51D Variant." Frontiers in Oncology, vol. 12, 2022, p. 959133, https://doi.org/10.3389/fonc.2022.959133.